User profiles for Jeffrey L. Winters
 | Jeffrey L. Winters, MDProfessor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine Verified email at mayo.edu Cited by 15416 |
[HTML][HTML] Deployment of convalescent plasma for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis. …
charged with reviewing, updating and categorizating indications for therapeutic apheresis. …
Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
…, PR Bauer, JE Blair, CM van Buskirk, JL Winters… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, JE Blair, CM Van Buskirk, JL Winters… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …
ZM Szczepiorkowski, JL Winters… - Journal of clinical …, 2010 - Wiley Online Library
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged
with a review and categorization of indications for therapeutic apheresis. Beginning with the …
with a review and categorization of indications for therapeutic apheresis. Beginning with the …
Transfusion-related acute lung injury: incidence and risk factors
…, P Wu, B Grimes, MJ Gandhi, JL Winters… - Blood, The Journal …, 2012 - ashpublications.org
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related
mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk …
mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, P Marks, CM van Buskirk, JL Winters… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study
Rationale: Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the
leading cause of transfusion-related mortality. Several transfusion characteristics have been …
leading cause of transfusion-related mortality. Several transfusion characteristics have been …
Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients
H Khan, J Belsher, M Yilmaz, B Afessa, JL Winters… - Chest, 2007 - Elsevier
Background Transfusion has long been identified as a risk factor for acute lung injury (ALI)/ARDS.
No study has formally evaluated the transfusion of specific blood products as a risk …
No study has formally evaluated the transfusion of specific blood products as a risk …
Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study
…, SA Khan, S Rana, JL Winters… - …, 2006 - Wiley Online Library
BACKGROUND: Using the recent Consensus Panel recommendations, we sought to
describe the incidence of transfusion‐related acute lung injury (TRALI) and transfusion‐associated …
describe the incidence of transfusion‐related acute lung injury (TRALI) and transfusion‐associated …